full comment requir non-u analyst conflict disclosur
pleas click link
canadian imperi bank
post-cal like setup competitor uc data atop dermat poc
continu wait see seem like transit year
rate growth solid volum provid strong tailwind hospic
clearli good lukewarm guidanc keep us shore
snap back rais price target
steadi perform focu shift swing factor price target
think broadli extraordinari time
insight result
margin toll steep order buy-back intact buy pullback
noisi quarter drive miss guid essenti line ramp steep
bar look achiev
guidanc revis impact window surfac revenu
catalyst sequenc attract scope pimavanserin set expand
first-tim guidanc underwhelm stock perform come execut
post call guid impress valrox excit build
note cfo
price prior day market close estimate unless otherwis note
global refer guid
global refer guid
thought rsa secur
postcard canada manag meet takeaway
model updat usher syndrom ii data remain near-term focu
largest increas largest declin
look rin sensit without sre
focu pc smartphon report
mostli coronaviru kernel sander
overal remain bullish lt trend select area secur spend
find research
insight www rbcinsightresearch com global research destin web contact capit market sale
repres access global research site
valu usd unless otherwis note
valu usd unless otherwis note
post-cal like setup competitor uc data atop dermat
like etrasimod potenti gain recognit best-in-class
modul lucr ibd indic upsid expans
atop dermat neuro indic see under-valued given strong
capit commerci potenti though reduc pt
increas expens guid vs estim compani
announc oper result market close today
opex quarter net cash posit focu remain
etrasimod pipelin develop progress potenti best-in-class
modul ibd expand indic specif focu
etrasimod develop ulcer coliti uc management commentari
impress suggest track complet elev uc
enrol second elev uc induct
expect initi later year slightli increas
estim reflect current trend per management commentari call
result decreas pt higher opex
estim near-term
report better expect result w/ consist room night
book revenu growth impress high profit level outlook
modestli wors fear due w/ see acceler y/i
declin spread global cautiou near-term reit outperform long-term pt
rundown book street higher
expect room night growth acceler throughout off-set
y/i declin adr in-lin guidanc due factor weak macro
 japan europ mix-shift lower adr market revenu
modestli consensu ebitda came
slightli ahead street leverag perform brand
spend guid call double-digit declin y/i book y/i
room night growth low-end due acceler impact
thru late-februari fundament trend mix acceler
room night growth steadi book growth contract ebitda margin
canadian imperi bank commerc tsx cm nyse cm
valu cad unless otherwis note
valu usd unless otherwis note
continu wait see seem like transit year
quarter low pcl scrub number lower still think
investor wait evid success expens save loan/revenu
quarter low pcl scrub number lower still think
investor wait evid success expens save loan/revenu
cm adjust ep well estim
consensu
took hard look scrub model takeaway
although loan growth stabil cm canada busi
acceler much previous model consequ canada
 revenu estim seem high lower made
small tweak canada commerci segment
cm announc million pre-tax restructur charg expect
reduc run-rat expens million
cm announc number execut chang effect march
cm disclos pro-forma cet ratio firstcarribean
transact close target
valuat seem attract still earli mani move part
us get posit stock time seem like cm use
year transit cost reduct manag chang cm trade
core ep estim vs peer averag price-to-book basi
cm trade vs peer averag
rate growth solid volum provid strong tailwind hospic
follow-up first glanc note date februari provid
addit thought result outlook updat
model maintain sector perform rate rais pt
ep plu upsid potenti buyback
close anoth strong beat driven better-than-
expect tailwind medicar hospic reimburs rebas
acceler admiss growth
roto-root also experienc continu solid organ growth core servic
line along contribut recent acquisit water restor
growth continu normal reach full penetr across exist
roto-root experienc margin pressur acquisit
market ramp time legaci market revenu profit
management guidanc came well previou expect could
prove conserv vita abl maintain recent admiss growth
trend roto-root abl deliv improv faster
rais pt continu reflect
ep plu potenti upsid buyback believ could done
valu usd unless otherwis note
valu usd unless otherwis note
clearli good lukewarm guidanc keep us shore
result ahead expect due higher-than-expect
consum product result pulp tailwind look ahead expect
compani end-market continu challeng capac add flat
guidanc new manag keep us sidelin
result expect due better-than-expect consum
product result adjust ebitda
forecast consensu januari compani provid updat
guidanc expect result larg in-lin
market expect increas price target reiter
manag guidanc impli adjust ebitda
midpoint prior forecast
expect y/i increas adjust ebitda reflect capit project benefit
shelbi expans project lower pulp price schedul
mainten outag combin tailwind partial off-set less
favor price/mix lower volum cost inflat combin
headwind adjust ebitda guidanc slightli
prior forecast
consum product adjust ebitda
forecast total consum product revenu
forecast driven higher-than-expect averag tissu price shipment
pulp paperboard adjust ebitda in-lin
forecast pulp paperboard sale slightli
forecast reflect lower-than-expect shipment volum
partial off-set modestli higher price
dk particularli weak think due rel
one-tim item like opex inventori hedg compani look
idr simplif major drop dkl also meaning cash come
door howev see high midland price difficult hurdl
overcom medium term
dkl simplif manag note look simplifi dkl
capit structur prepar balanc sheet potenti asset drop-down
would like includ idr simplif drop spring
gather asset dkl would potenti fund drop combin dkl
unit debt plan evalu drop time goe would
expect idr simplif result addit dkl unit flow dk
current valu idr million cash flow
still focus sharehold return dk announc increas
dividend mark sixth straight quarter dividend increas
seventh increas sinc dk signal plan continu increas
dividend although see less point current dividend yield
valu usd unless otherwis note
screen well peer group averag share repurchas
front dk provid guidanc provid
past million remain capac dial back repurchas
assumpt million versu million
estim move lower throughput higher oper expens
ep estim ebitda estim
year move primarili driven lower throughput
tyler higher sg expens price target move
snap back rais price target
deliv strong result revenu bill growth well
consensu acceler q/q top-lin beat drove better expect
margin quarter driven core product secur focu
call ga launch siem maintain outperform rais pt
higher estim
need know report strong result across board
broad-bas strength includ bounce-back quarter feder close
slip deal depend remaind close
none lost competitor almost metric expect
includ revenu acceler cc vs consensu
calcul bill growth cc vs consensu elast
cloud continu standout revenu cc
account major growth subscript custom monthli
saa revenu continu total revenu remind
headwind dr conjunct result manag announc cro
aaron katz leav role svp sale justin hoffman head
sale search conduct sens next stage growth
compani look proven leader experi build
run multibillion-dollar scale organ chang
reflect underli issu follow strong quarter macro remain posit
compani note doesnt expect company-specif impact
coronaviru maintain outperform rate rais price target
steadi perform focu shift swing factor price target
manag continu hold billion ebitda tough environ bull
case assum hold leverag move toward enterpris valu
shift debt equiti time bear case see downsid risk ebitda/
cash flow near term focu vasostrict litig cch opportun
swing factor share still lever opioid headlin expect continu
volatil price target
modestli increas ebitda billion
billion billion net debt billion net leverag
on-going opioid litig well understood expect investor focu
valu usd unless otherwis note
valu usd unless otherwis note
pivot near-term swing factor specif gener risk vasostrict trial
may adrenalin potenti entri time unclear
opportun cch pdufa juli
vasostrict adrenalin collect million combin
roughli total revenu given higher margin natur closer
ebitda face potenti gener risk vasostrict
mandatori mediat hear earli march trial set
may stay octob consensu reflect growth
adrenalin could see competit around total
receiv second expect late-april fda respons
ad visibl limit time appear factor
competit impact
cch opportun less clear also believ expect low
limit contribut begin infrastructur
build start suspect come quarter street model
captur cost associ commerci product still
limit opportun rel believ like see consensu
million risk adjust unclear
think broadli extraordinari time
despit beat enlc lag current commod tape maintain
outperform rate view commod improv deck
shift sentiment pretti quickli enlc taken action lower dividend remov
cost key commod improv allow support well
connect manag stack declin deliv permian growth reduc price
target reflect increas risk volum
detail enlc gener ebitda
street estim enlc gener
dcf provid distribut coverag quarter
north tx oklahoma cash flow beat estim permian cash flow
due part roll-off one mvc
report clean beat revenu ebitda vs street est
revenu guidanc came street expect ebitda guidanc
came in-lin street mid-point chang est pt
grew y/i vs y/i ex-reverb vs
street revenu grew y/i
street driven upsid seller servic revenu gener
strong holiday season ebitda margin came rbc/
street compani guid revenu
street ebitda bracket
street fundament mix gmv growth acceler
y/i highest seen sinc though includ reverb ebitda margin
valu usd unless otherwis note
valu usd unless otherwis note
nutanix deliv good quarter subscript transit acceler
subscript revenu y/i revenu
expect focu like outlook howev term
acceler transit potenti impact impact
bill respect despit remain posit
opportun maintain op decreas pt lower estim
need know nutanix deliv good quarter highlight
acceler subscript transit subscript revenu grew y/i
revenu bill subscript
q/q ahead goal near goal
experienc subscript transit acceler weigh
short-term outlook result reach side transit faster
case expect impact bill compani also
note potenti impact could impact bill
off-set plan expens reduct due paus
chang exclud two event manag note
sever larg deal japan slate business/meet
delay across apac compani also feel suppli chain
might tight ok remain unknown
point though commod hardwar approach like less impact
other overal remain posit opportun look forward
analyst day expect detail around subscript
transit maintain op decreas pt valuat remain
attract ev/
valu usd unless otherwis note
valu usd unless otherwis note
strong perform led hawaii seen
demand impact hawaii yet fact might lower
crude cost howev expect like remain overhang near
term think uniqu disadvantag current low distil crack
report adjust ep consensu
estim partial due
million realiz hedg gain mostli revers howev
refin margin hawaii tacoma stronger expect
manag highlight seen impact demand associ
market chines refin run cut signific
help allevi demand declin asian market also note
demand weak caus high differenti compani pay
crude abat somewhat posit howev given tourism
industri hawaii focu jet fuel sale market easi
imagin demand could eventu impact viru spread
mark heavi turnaround year capital-expenditure incl
turnaround fall million rang record
level turnaround expect east million
wyom million tacoma million
capit spend declin meaning rbccme million per year
major turnaround time period
ep estim move primarili
driven stronger refin perform hawaii well slightli stronger
assumpt logist retail price target move
call map path key manufactur progress
pivot studi initi data readout believ transform
commerci stage gene therapi compani potenti muscular dystrophi
asset approv next given signific progress commerci
grade microdystrophin manufactur gmp releas expect
key overhang stock view expect increas attent
like share appreci approach sever key gene therapi
catalyst spread continu believ valuat
reflect potenti out-year revenu believ dmd
lgmd gene therapi could provid option earlier-stag asset
critic mass gene therapi product develop capabl
compani continu build
map path key manufactur progress pivot studi
initi data readout believ transform commerci
stage gene therapi compani next
manufactur progress mitig key overhang stock view
expect increas attent like share appreci approach key
gene therapi catalyst spread
continu believ valuat reflect promis dmd lgmd
gene therapi option earlier-stag asset critic mass
gene therapi capabl continu build
price target increas model updat
valu usd unless otherwis note
valu usd unless otherwis note
sq post solid print guid leav door open potenti good
news upcom analyst day reiter outperform rate increas target
price
result squar report total net revenu impli
adj revenue y/i forecast deceler
post adj ebitda forecast
app rev increas y/i exclud
guidanc gener line compani provid last quarter
manag provid offici guidanc revenu
gross profit adjust ebitda
upsid margin reinvest call manag note
compani gener top-lin out-performance intend
increas adj ebitda guidanc opt reinvest instead
adjust estim increas target price given guidanc quarterli
result increas total net revenu lower
adjust ebitda estim rais total net revenu
adjust ebitda
new adjust ep estim
base
revis number also increas target price base
ev adjust revenu line softwar payment
insight result
result better expect across metric notabl mgmt
revenu guid impli growth mp top street mean
impress revenu progress driven combin new member
add cross-sel rapidli increas visits/utilizationand doesnt yet includ
contribut intouch also demonstr abil scale via
continu ebitda margin expans rais pt
revenu ebitda guidanc ahead consensu tdoc
revenu guid impli growth mp well
ahead street mean believ buy-sid
consensu ebitda guid also better expectedtdoc target
compar consensu impli healthi
bp mp margin expans notabl sinc intouch acquisit
expect close rang assum contribut
result better expect revenu visit came ahead
even jan pre-announc -- revenu yoy
visit yoy ebitda well ahead street
rais pt intouch acquisit strengthen confid
abil sustain organ revenu growth longer better balanc
strategi provid vs payer/consum distanc peer
virtual health leader sinc transact expect close
yet layer publish model/estim purpos
valuat howev adjust pro-forma impact revis
pt base multipl revenu estim includ
expect run-rat revenu lift intouch valu
saa averag well peer high-end rang
heel strong remain impress multipl revenu
lever toward next year said valuat adequ reflect
compani long-term global growth prospect current momentum
shareholder-friendli initi believ unlik rerat higher
today rais ep pt reiter sector perform
valu usd unless otherwis note
impress share gain across banner consolid comp
marmaxx homegood canada
margin guid straight year investor
adjust mute ep growth given consist homegood self-
help abat freight suggest conservat
pre-tax outlook expect ep growth
total top line comp contribut buyback
comp continu outperform expect growth could land closer
rang
rais ep target ep includ
vs guid target appli
ep
margin toll steep order buy-back intact buy pullback
ep declin magnitud
margin reset disappoint part pressur remain backward look
abat time tbv see support compel
rel valu opportun buyback order strength inflect margin
upsid catalyst maintain op though lower pt impli
reset lower still posit step-up ep rote
ep declin weve street
long time gm sg came wors expect
gm estimate ex-interest vs prior guid
ex-interest driven lower ca/pacif result particularli
relat delay cost overrun metro cross said time also
play key role result still reflect lag weak last year
softer sell environ fundament improv order
valu usd unless otherwis note
came est price power seen check well
management commentari help margin later year
sg estimate move bp y/i vs prior
guid driven higher comm count ramp cost system upgrad
partial off-set higher rev also expect buyback weight
vs flat share count guid assum bn buyback
vs bn prior importantli estimate declin
rote still ramp given better
demand margin improv buyback credibl concern may
weigh stock nt continu see upsid tol multipl lt
roe stori step-up play
deliv revenu ebitda slightli rbc/street revenu
growth remain consist y/i new ceo hayden brown
present invest year focu attract bigger client
enabl spend per client better penetr key tech vertic investor
will look could see upsid lower est maintain outperform pt
strong result revenu deceler y/i vs rbc/
street driven slow net add vs net add
partial off-set increas take rate vs
ebitda came well rbc/street
upsid larg come better-than-expect take-r leverag within
 gross margin expans improv cloud comput cost
vs guid call full year
note compani guid ebitda
full year focus growth overal fundament trend
posit modest top-lin out-performance profit expect
come well estim
valu usd unless otherwis note
valu usd unless otherwis note
noisi quarter drive miss guid essenti line ramp steep
expect weak share thursday miss though earn
guidanc within consensu miss expect due
particularli noisi quarter ahead pdgm ebitda shortfal versu
street reflect disrupt departur realign
home health platform includ staff replac busi
consolid seven divis nine
addit compani
incur higher disrupt relat pdgm
prepared lower case mix drove top-line
margin headwind initi ebitda-mi guidanc rang essenti line
expect captur consensu high end though street
under-model earn ramp year indic
hh preview avail manag work offset pdgm rate
headwind expect neutral juli implement therapi util
cost manag effort cours year
asid nois encourag organ momentum
legaci almost famili agenc togeth achiev impress
organ admiss growth pace toward growth
versu growth includ full year guidanc suggest
initi outlook could conserv
manag also remain track initi includ sustain
pace acquisit acquir revenu ad roster
fourth quarter bring total
bar look achiev
adj ebitda-mi vs consensu
compani continu see solid acut top-line growth off-set higher
labor cost lead margin contract behavior health show
improv remain long-term plan
guidanc bracket consensu high end achiev
adj ebitda rang repres yoy growth top-line growth
assum continu recent trend acut adj ebitda msd
behavior flat yoy
confer call et dial-in
valu usd unless otherwis note
valu usd unless otherwis note
guidanc revis impact window surfac revenu
announc would miss segment revenu guidanc result
compani quantifi impact top
bottom line lay potenti impact scenario variou degre
warn investor would miss segment revenu specif
window oem surfac revenu impact
yet quantifi size miss provid hand
scenario show potenti impact compani margin earn
valu usd unless otherwis note
valu usd unless otherwis note
model sale growth con ep in-lin
base channel work believ estim reason
estim assum growth us growth intern
gross sale comp januari easi versu remind investor
januari gross sale growth believ underli gross sale
expect continu us momentum channel work suggest us net
sale growth estim reason accord iri us sale growth
dec averag basi past
quarter us net sale growth averag outpac scanner
bp impli growth
upsid rel consensu intern analyst day
novemb top market brazil canada franc
poland south africa spain assum
market account sale remain grew rough back
envelop math get us intenational revenu growth low vs
rbce alpha con ccep suggest monster perform
well strong innov pipelin also point
ccep suggest got great trial poor repeat believ
function tast reformul mimic us product plan
roll-out march
catalyst sequenc attract scope pimavanserin set expand
solid nuplazid revenu guidanc serv attract backdrop
sequenc catalyst laid beyond build nuplazid current
commerci growth unlock expans valu pimavanserin across sever
high opportun indic includ near-term sizabl drp market
path potenti snda approv year-end continu view acad late-
stage neuropsych franchis high qualiti underappreci drp
path crystal well key program matur around pim broader
util see attract cadenc event ahead support collect multi-
billion dollar year sale opportun potenti drive upsid
reiter pt outperform rate
financi nuplazid continu solid trajectori guidanc
well-receiv reflect commerci growth late-stag pipelin deliveri
net-net continu solid growth y-o-i expans well-
receiv histori beat rais coupl meaning
opportun continu elev growth pdp base recept
prescriber/pati market base compani initi
drp opportun track sever mileston event toward year-end
approv key prepar phase foundat robust late-
stage pipelin activ underway pre-snda meet summer snda
submiss potenti culmin year-end approv given
breakthrough design potenti prioriti review manag see
agre likelihood adcomm continu see high
probabl approv drp program account valuat
driven peak potenti sale
rest pipelin also matur top-line readout three pivot
trial expect set robust cadenc
catalyst direct tie market expans overal look
develop pivot trial believ success label
expans nuplazid add alreadi signific string revenu
opportun per call manag post-earn remain activ
pursuit promis next-gen molecul long-term bd object
stay cogniz ex-u pim opportun especi asia market
partnership
first-tim guidanc underwhelm stock perform come
share sold follow result deliv solid quarter
came lower expect guidanc narr could chang
put togeth string beat rais suspect conservat
guidanc repeat guide-down past mean least
lost benefit doubt chang price target
first-tim guidanc underwhelm despit suspect
conservat built introduc ebitda guidanc million
million midpoint impli base busi growth
back pro-rat avkar contribut deal close
despit ramp gener gross margin toward upper year-end
new contribut gener caraf eluryng dec launch
suspect two primari reason behind disconnect like guid
conserv given compani histori miss expect ii
street may under-model opex spend assum continu declin
sg updat model rais ebitda
forecast million million million includ million
new ebitda avkar year larg off-set higher spend
post call guid impress valrox excit build
expans commerci prepar focu rest valrox approv decis
commerci launch see attract setup given modest launch
expect maintain pt outperform rate
valu usd unless otherwis note
report result provid detail revenu guidanc
valrox commerci launch remain major focu
earn call market close announc financi result
total revenu slightli estim though larg in-lin
st note varianc vs st larg driven vimizim
weak rev vs st could attribut
lumpi ex-u govern order indic chang
valu usd unless otherwis note
valu usd unless otherwis note
note cfo
recent host new cfo garth harkinson head
investor relat patti yahn-urlaub investor meet
capit alloc canopi ballast point fresh investor mind
surpris new cfo would question
capit alloc messag consist
written sinc newland took ceocurr manag
believ exist larg deal would enhanc valu organ
growth biggest area focu given opportun beer
portfolio occur tuck-in varieti mr harkinson
commit deliv constel previous state capit return
object bn
time wine divestitur last quarter compani indic close
deal gallo end fiscal year end constel fiscal
year tomorrow leav much time make announc
base gallo deal essenti done constel need receiv final
ftc approv paul masson cook roget hold
order deal complet aspect must final hope
gain clariti final transact time constel
report earn april constel also work hard address
strand cost divestitur contact suggest
work well way
postcard canada manag meet takeaway
host high-demand investor meet sector perform-r flowserv
ceo scott row toronto montreal week mr row first full-
schedul ndr sinc join bottom line
valu usd unless otherwis note
valu usd unless otherwis note
still much fix continu thoroughli impress mr
row progress date battl plan achiev target
highlight investor meet ceo scott row
host high-demand investor meet presid ceo
scott row investor relat head twice interim cfo jay rouech
toronto montreal week mr row first full-schedul
non-deal roadshow sinc join suggest us
feel import corner turn
transform consist ready-for-primetim theme compani
provid updat progress toward financi target
report earn overal hard impress mr
row west point hb credenti along commerci intens
lean manufactur know-how also better appreci
much-need wholesal upgrad mr row direct report replac
multipl change-out board director look ahead
coronaviru commot contain compani oil ga exposur
view construct investor expect see meaning
multipl expans base oper improv engin
plan gotten bit capit effici although complet time
push product well prior expect
substant updat progress toward midstream monet
continu think would transform increasingli appear
bid-ask wide
budget get slight haircut announc formal capital-expenditure
budget million preliminari guid releas januari
million manag reiter focu gener
budget essenti cf neutral million
budget gener yoy product declin nearli
midpoint guidanc mid-singl digit growth remain
expect meaning product dip well time releas
product guidanc kboe/d oil repres
sequenti declin prior consensu kboe/d oil
still progress midstream monet manag express high
level confid abil gener proce midstream
invest howev reason underli confid appear
manag assess asset qualiti continu see
midstream sale like transform appear increasingli like
wide bid-ask spread asset
design adjust pay product dividend
follow space issu see enhanc product
wider space bakken complet base go forward plan
cfp estim
market data usd financi data eur dividend paid
valu usd unless otherwis note
model updat usher syndrom ii data remain near-term focu
focu near-term interim readout studi usher
syndrom type ii late see underappreci catalyst
attract risk/reward prqr updat model report
maintain pt outperform rate
morn prqr announc financi result provid sever
updat around ophthalmolog pipelin lead asset sepofarsen
current evalu registr studi top-line
result expect howev near term focu remain readout
stellar studi usher syndrom type ii
remain track late readout convers suggest
investor expect remain low given treatment rare form
progress blind exist complic associ use novel
ophthalmolog endpoint without robust natur histori diseas
chang revenu estim
host meet servicenow gina mastuono cfo dave schneider
presid custom op lisa bank vice-president investor relat came
away greater convict around compani growth durabl support
grow uptak sku non-itsm product vertic expand
use case reiter pt op rate
host meet servicenow gina mastuono cfo dave schneider
presid custom op lisa bank vice-president investor relat
came away greater convict around compani growth durabl
support grow uptak sku non-itsm product vertic
expand use case reiter pt op rate
follow keith block departur salesforc comment
opinion like next destin
valu usd unless otherwis note
valu usd unless otherwis note
decreas short interest small-cap si large- mid-cap
saw increas si perhap due failur dian-tu trial
potenti impact fda view aducanumab though increas could
off-set tecfidera patent victori
si saw larg decreas perhap reflect investor sentiment
strong trikafta launch report earn
si small-cap decreas
valu usd unless otherwis note
global refer guid coronaviru
situat continu evolv china across globe report
global refer guid compani coverag univers
could impact coronaviru outbreak
report identifi compani global sector exposur china
either suppli demand impact potenti second deriv factor
analyst identifi compani alreadi warn earn
impact also note adjust earn estim
reflect potenti fallout link variou report within
global research referenc event around impact stem
outbreak surprisingli given exposur european coverag univers
effect pass report har
resourc investor look find opportun indirect exposur china
within coverag univers
largest increas largest declin
averag short interest percentag float coverag
two-week period end februari consist period end
stock highest short interest
respect show largest increas short interest
januari period
lowest short interest level
respect largest declin short
interest percentag float respect
drax result line coal closur announc
greencoat uk wind result add colour previous announc
valu usd unless otherwis note
valu gbp unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
edp china three gorg abb edp mubadala leav
qualifi sharehold posit
acciona look sell facil servic busi
eiffag dividend beat like vinci
nation expect ep chang u/l upgrad given fx
getlink guidanc consensu ebit beat thank
gran tierra energi gte to/gt line headwind requir chang
tack hurrican energi hur cfo resign global refer guid
look rin sensit without sre
us crack indic week region
week east coast mid-con bbl screen
weakest region ulsd crack bbl rbob crack
bbl versu brent week
crude spread neg week light side clearbrook
ll notabl neg move midland remain rel unchang
medium heavi crude mar maya wc narrow
trump administr offici appli circuit biofuel exempt rule
nationwid accord bloomberg trump administr decid
shave back small refineri exempt sre renew fuel standard
rf respons feder court rule last month court rule
refineri continu held exempt sinc start rf
elig continu receiv exempt think potenti
refineri univers could lose sre interpret rin
increas price news
neg impact typic rin-expos name dk howev
dk histor receiv sre well go
away see dk similar sensit rin price
formerli led wide margin still see littl exposur
focu pc smartphon report
take-away coronaviru continu spread
seen neg pre-announc amphenol
name within coverag univers anticip wors origin
expect compani provid guidanc calendar
calendar perceiv less riski name univers highlight
global refer guid coronaviru
valu usd unless otherwis note
situat continu evolv china across globe report
global refer guid compani coverag univers
could impact coronaviru outbreak
report identifi compani global sector exposur china
either suppli demand impact potenti second deriv factor
analyst identifi compani alreadi warn earn
impact also note adjust earn estim
reflect potenti fallout link variou report within
global research referenc event around impact stem
outbreak surprisingli given exposur european coverag univers
effect pass report har
resourc investor look find opportun indirect exposur china
within coverag univers
mostli coronaviru kernel sander
report recap investor view coronaviru elect
domin convers investor last week week
weve continu sens long-onli commun hasnt much
term reposit portfolio coronaviru also sens
investor take sanderss surg serious
also discuss assess risk us equiti issu
coronaviru would surpris see fall
high consist low volume unwind
doesnt hold index could fall rang total drop
consist growth scare
risk ep tougher gaug updat coronaviru stress
test use would also becom attract p/
 fall
elect argu investor may rattl bloomberg
loss momentum sanderss surg expect close race novemb
think investor correct take sanderss surg serious also note
presidenti elect year tend exhibit trend-lik return term
sector risk util reit two major sector
carri signific polici risk sander risk seem highest
financi
thought rsa secur confer
overal remain bullish lt trend select area secur spend
high level overview despit concern coronaviru
impact attend ground meet dozen public
privat secur vendor past sever day annual rsa
secur confer overal found confer help pack
usual convers vendor buyer center around sever
autom softwar vs human overal focu data
secur hybrid-cloud world increas regul on-going
debat best breed vs consolid play follow report
season saw secur vendor trade higher post result gener
show good top line trend increas level spend mani
valu usd unless otherwis note
valu usd unless otherwis note
question investor spoke focus tri identifi company-
specif product catalyst area vendor misunderstand
might gap result outlook valuat coronaviru
peopl mind didnt walk away hear mani vendor cite
issu although situat progress rapidli think earli
mani call addit sever public compani highlight
within note also met sever high-profil privat softwar vendor
pleas follow detail
capit market busi name use certain branch subsidiari royal bank canada includ dominion secur inc
capit market llc europ limit royal bank canada hong kong branch royal bank canada sydney branch inform contain
report compil capit market sourc believ reliabl represent warranti express impli made royal
canada capit market affili person accuraci complet correct opinion estim contain
report constitut capit market judgement date report subject chang without notic provid good faith without
legal respons noth report constitut legal account tax advic individu tailor invest advic materi prepar gener
circul client prepar without regard individu financi circumst object person receiv invest
servic contain report may suitabl recommend consult independ invest advisor doubt
suitabl invest servic report offer sell solicit offer buy secur past perform guid
futur perform futur return guarante loss origin capit may occur capit market research analyst compens base
part overal profit capit market includ profit attribut invest bank revenu everi provinc canada state
 countri throughout world law regul type secur invest product may offer
resid well process result secur discuss report may elig sale jurisdict capit
market may restrict publish research report time time due regulatori restrict and/ intern complianc polici case
latest publish research report avail client may reflect recent materi chang applic industri and/or applic subject compani
capit market research report current date set forth research report report circumst
constru solicit act secur broker dealer jurisdict person compani legal permit carri busi
secur broker dealer jurisdict full extent permit law neither capit market affili person accept
liabil whatsoev direct indirect consequenti loss aris connect use report inform contain herein
matter contain document may reproduc copi mean without prior written consent capit market instanc
addit inform avail request
public approv capit market llc member finra nyse sipc regist broker-deal accept
respons report dissemin unit state recipi report regist broker-deal bank act
broker dealer capac wish inform regard effect transact secur discuss report
contact place order capit market llc
public approv dominion secur inc member iiroc canadian recipi report design institut
ontario accredit investor british columbia alberta sophist purchas quebec similar permit purchas provinc
wish inform regard effect transact secur discuss report contact place order
dominion secur inc without way limit forego accept respons report dissemin canada
public approv europ limit el author prudenti regul author regul
conduct author fca prudenti regul author connect distribut unit kingdom materi gener
distribut unit kingdom retail client defin rule fca rbcel accept respons report dissemin
unit kingdom
materi distribut germani europ limit frankfurt branch regul bundesanstalt fr finanzdienstleistungsaufsicht bafin
receiv advic australia
materi distribut australia royal bank canada sydney branch abn afsl materi prepar
gener circul take account object financi situat need recipi accordingli recipi act
materi consid appropri materi regard object financi situat need materi relat acquisit
possibl acquisit particular financi product recipi australia obtain relev disclosur document prepar respect product
